Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic metronidazole-induced MRI changes.

C K Horlen1, C F Seifert, C S Malouf

  • 1School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock 79430, USA.

The Annals of Pharmacotherapy
|December 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation in vitro.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2002
Same author

Administration of medications through enteral feeding catheters.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·1997
Same author

General principles of acute poisonings.

South Dakota journal of medicine·1996
Same author

A nursing survey to determine the characteristics of medication administration through enteral feeding catheters.

Clinical nursing research·1995
Same author

Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity.

The Annals of pharmacotherapy·1994
Same author

Topical nitrate treatment of impotence.

The Annals of pharmacotherapy·1993
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Metronidazole accumulation in patients with liver dysfunction can cause central nervous system (CNS) and peripheral neuropathy. This case highlights MRI changes associated with metronidazole toxicity, emphasizing dose reduction in liver impairment.

Area of Science:

  • Neurology
  • Pharmacology
  • Radiology

Background:

  • Metronidazole is a commonly prescribed antibiotic.
  • Liver dysfunction can impair drug metabolism and increase the risk of toxicity.
  • Neurological complications associated with metronidazole are well-documented.

Observation:

  • A patient with cirrhosis and hepatitis C developed ataxia, disorientation, and peripheral neuropathy while on metronidazole therapy.
  • Magnetic resonance imaging (MRI) revealed characteristic signal changes in the brainstem and cerebellum after significant metronidazole accumulation.
  • Toxic serum metronidazole concentration was confirmed.

Findings:

  • This case demonstrates metronidazole-induced neurotoxicity, evidenced by clinical symptoms and specific MRI findings.

Related Experiment Videos

  • The observed MRI changes, including increased signal intensity in the cerebellar and brainstem regions, are consistent with metronidazole accumulation.
  • The patient's liver dysfunction likely contributed to the elevated and toxic serum levels of metronidazole.

    • Implications:

    • This case underscores the importance of cautious metronidazole dosing in patients with hepatic impairment to prevent neurotoxicity.
    • Healthcare providers should be vigilant for neurological symptoms in patients with liver dysfunction receiving metronidazole.
    • Awareness of these potential MRI changes can aid in the diagnosis and management of metronidazole-induced neurotoxicity.